The study, led by Yihui Zhang, Yujun Mo, and colleagues including YunGang Wu and Zhouguang Wang, was built around a clear-eyed assessment of why existing approaches fall short. Electroacupuncture is already used clinically in spinal cord injury rehabilitation and can dampen inflammation and boost neurotrophic factors, the signaling molecules that nourish neurons. But on its own, it cannot reverse the death of neurons or repair broken neural circuits, and its effectiveness is limited by the fact that injured tissue conducts electricity poorly. Conductive hydrogels and electroactive scaffolds can partially restore electrical continuity across a lesion, yet they do little to suppress the oxidative storm raging within it. Antioxidant hydrogels, conversely, can mop up reactive oxygen species but lack sustained electrical coupling. And stem cell transplants, however promising, face a brutal reality: bone marrow mesenchymal stem cells, or BMSCs, transplanted into the injury site are themselves vulnerable to the very oxidative stress and ferroptosis that make the environment hostile in the first place.

The researchers’ solution was a composite material they call HBP@BMSCs. The hydrogel matrix is made from dopamine-grafted hyaluronic acid, a polymer that combines the biocompatibility of hyaluronic acid, a natural component of tissue, with the adhesive properties of catechol groups, allowing it to cling tightly to the irregular surfaces of a spinal cord lesion. Suspended within this matrix are nanoparticles of polypyrrole, a well-known conductive polymer, loaded with baicalin, an antioxidant compound derived from the medicinal herb Scutellaria baicalensis. Baicalin does double duty: it directly scavenges free radicals and activates the Nrf2/ARE antioxidant signaling pathway, upregulating endogenous protective proteins such as HO-1, NQO1, and GPX4. The phenolic hydroxyl groups on baicalin also crosslink with polypyrrole to form a conductive nanonetwork whose electrical properties fall within the range of neural tissue, allowing it to carry bioelectric signals through the lesion.

The material itself was carefully engineered. Nuclear magnetic resonance confirmed the dopamine grafting onto hyaluronic acid, and ultraviolet-visible spectroscopy verified that baicalin had been successfully incorporated into the polypyrrole nanoparticles, which grew from roughly 168 to 228 nanometers in diameter after loading. The finished hydrogel gels in about five minutes at body temperature, can be extruded through a syringe, and exhibits shear-thinning behavior, meaning it becomes less viscous under pressure and can flow into the complex geometry of a wound cavity before re-solidifying. At an optimized baicalin-polypyrrole concentration of 0.6 milligrams per milliliter, the hydrogel reached a conductivity of approximately 6 to 7 millisiemens per centimeter, comparable to other conductive hydrogels used in spinal cord repair, while keeping cell viability above 98 percent. Baicalin was released gradually from the matrix over roughly 240 hours, providing sustained antioxidant protection during the most dangerous window of secondary injury.

In laboratory tests, the hydrogel proved remarkably protective. When BMSCs or PC12 cells, a neuron-like model line, were exposed to tert-butyl hydroperoxide to induce oxidative stress, or to erastin, a chemical that triggers ferroptosis, the presence of the HBP hydrogel dramatically reduced reactive oxygen species accumulation and reversed the rise of 4HNE, a hallmark marker of lipid peroxidation, along with ferritin light and heavy chains that signal iron overload. Flow cytometry confirmed that BMSCs cultured inside the hydrogel for 24 hours retained their stem cell identity, with more than 95 percent expressing the mesenchymal markers CD73 and CD90 and fewer than 2 percent expressing the hematopoietic markers CD34 and CD45. In other words, the material sheltered the cells without changing what they were.

The in vivo experiments were conducted in adult female C57BL/6 mice subjected to a standardized compression injury at the T9-T10 vertebral level, with seven treatment groups ranging from saline controls to the full combination of hydrogel-delivered BMSCs plus electroacupuncture. Investigators assessing behavior and quantifying images were blinded to group allocation. Electroacupuncture was administered twice daily for 14 consecutive days at the GV14 and GV4 acupoints, using a 1.0 milliamp current at 4/10 hertz for 15 minutes per session. Seven days after injury, the combined therapy group showed the lowest levels of 4HNE and the highest levels of GPX4, the glutathione-dependent enzyme that stands as the principal brake on ferroptosis. Western blotting revealed that the combination suppressed the oxidative stress proteins COX2 and NOX2 while restoring XCT, GPX4, and SOD1, and that it most strongly activated Nrf2, the master transcriptional regulator of antioxidant defense.

The therapy also tackled the iron problem head-on. After spinal cord injury, disruption of the blood-spinal cord barrier and hemorrhage cause iron to accumulate abnormally in the lesion. Transferrin receptor, which imports iron, rises while ferroportin, which exports it, falls, and ferritin stores swell as cells struggle to buffer the excess. Prussian blue staining showed abundant iron deposits in untreated injured mice, and transcriptome sequencing confirmed that gene sets for iron ion transport and intracellular iron homeostasis were preferentially enriched toward the injury phenotype. The HBP@BMSCs plus electroacupuncture group reversed this pattern most decisively, reducing ferritin and transferrin receptor expression while restoring ferroportin, thereby relieving the intracellular iron load that fuels the Fenton reaction and the vicious cycle of lipid peroxidation. Neuronal apoptosis, measured by cleaved caspase-3 and the Bax-to-Bcl-2 ratio, fell in parallel, and more neurons survived in the lesion core.

Perhaps the most striking results concerned regeneration. Thirty days after treatment, CM-DiI-labeled transplanted BMSCs in the combination group showed markedly increased colocalization with NeuN, a mature neuronal marker, indicating that the cells had differentiated toward a neural lineage. Corticospinal tract tracing, performed by injecting a light-sensitive mCherry-expressing virus into the sensorimotor cortex, revealed abundant regenerating fibers extending through and beyond the lesion in the combination group, whereas injured controls showed almost none. NF200-positive neurofilaments crossed the glial scar boundary marked by GFAP, and the scarred area itself shrank. The conductive BA-PPy component proved essential: a control group receiving BMSCs in plain hyaluronic acid hydrogel with electroacupuncture, but without the nanoparticles, showed substantially weaker neurotrophic signaling, less neuronal differentiation, and poorer circuit reconstruction, demonstrating that the material was actively conducting and amplifying the electrical stimulation rather than merely serving as a passive carrier.

Function followed structure. Using the Basso Mouse Scale and an AI-powered gait analysis system based on DeepLabCut pose tracking, the researchers quantified hindlimb recovery over 30 days. Mice receiving the combined therapy achieved the highest BMS scores, greater muscle strength, longer gait cycles, and higher hip and toe heights, with joint movement amplitudes at the knee, ankle, and toe significantly improved compared with every other group. Motor-evoked potentials recorded from the gastrocnemius muscle after stimulation above the lesion reached their greatest amplitude in the combination group, confirming that signals could once again traverse the injury site. Histology showed preserved tissue architecture, reduced cavity formation, and abundant Nissl bodies, the protein-synthesis machinery of healthy neurons, in the lesion area. Major organs examined 30 days after treatment showed no pathological abnormalities, suggesting the treatment was systemically safe.

The study stops short of human application, and the hurdles between a mouse model and a clinical therapy for spinal cord injury are formidable. But the conceptual advance is significant: rather than treating the biochemical and bioelectrical dimensions of spinal cord injury separately, the researchers fused them into a single intervention in which a conductive, antioxidant, cell-laden matrix transforms electroacupuncture from a modest symptomatic therapy into a driver of genuine regeneration. By simultaneously scavenging reactive oxygen species, restoring iron homeostasis, blocking ferroptosis, protecting transplanted stem cells, and transmitting electrical cues that steer those cells toward neural fates, the platform addresses the interlocking failures that have limited regenerative medicine after spinal cord trauma. If the synergy holds in larger animal models, the humble needle, paired with an engineered gel, may yet become an unexpected centerpiece of spinal cord repair.

Subject of Research: A conductive anti-ferroptosis hydrogel combined with electroacupuncture for spinal cord injury regeneration

Article Title: Electroacupuncture synergizes with anti-ferroptosis bioelectrical niche remodeling to promote spinal cord regeneration

Article References: Zhang, Y., Mo, Y., Yan, B., Wang, X., Wu, P., Wu, Y., & Wang, Z. (2026). Electroacupuncture synergizes with anti-ferroptosis bioelectrical niche remodeling to promote spinal cord regeneration. Materials Today Bio, 41, Article 103708. https://doi.org/10.1016/j.mtbio.2026.103708

Image Credits: AI Generated

DOI: 10.1016/j.mtbio.2026.103708

Keywords: spinal cord injury, electroacupuncture, ferroptosis, hydrogel, stem cells, polypyrrole, baicalin, oxidative stress, iron homeostasis, neural regeneration, biomaterials, conductive scaffold

The research began with a deceptively simple observation. Breast cancer patients frequently experience chronic stress disorders alongside disruptions of the gut microbiota, a state known as dysbiosis. Whether these two phenomena merely coexist or actively conspire to worsen outcomes has been unclear. To probe the question, the researchers turned to mouse models in which chronic stress could be induced and its consequences on breast cancer behavior measured. What they found was striking in its specificity: stress did not make the primary tumors grow faster. Instead, it left tumor growth essentially untouched while dramatically enhancing metastasis, particularly to the lungs, and reshaping the immune environment at the metastatic site. The distinction matters enormously, because most cancer therapies are designed to shrink tumors, while metastasis, the process by which cancer cells seed new colonies in distant organs, is what ultimately kills most patients.

Using 16S rDNA sequencing to catalog the gut bacterial communities of stressed and unstressed animals, the team zeroed in on Alistipes putredinis as a key player. This bacterium expanded under chronic stress conditions, and its expansion correlated with the surge in lung metastases. But the microbe itself was only part of the story. A. putredinis is a producer of indole-3-acetic acid, a metabolite generated from the dietary amino acid tryptophan. Targeted tryptophan metabolomics confirmed that stressed animals carried elevated levels of this bacterial product, linking a specific microbial species, a specific biochemical pathway and a specific pathological outcome into a single chain of evidence.

The mechanistic heart of the paper lies in how IAA actually helps cancer cells travel. Working with 4T1 cells, an aggressive mouse breast cancer line commonly used to model metastatic disease, the researchers showed that IAA promotes cell migration through a signaling pathway centered on the aryl hydrocarbon receptor, or AhR. AhR is a ligand-activated transcription factor best known for sensing environmental and dietary chemicals, including many microbial metabolites, and it has increasingly been implicated in cancer biology and immune regulation. According to the study, IAA’s engagement of AhR drives oxidative stress within the cancer cells, and that oxidative burden somehow equips them to migrate more effectively. When the team administered CH223191, a well-characterized pharmacological inhibitor of AhR, the migration of 4T1 cells was suppressed in vitro, and metastasis was inhibited in vivo. In other words, blocking the receptor that IAA activates was enough to sever the link between the bacterial metabolite and the spread of cancer.

Enter baicalin, the compound that gives the study its therapeutic punch. Baicalin has previously been credited with antitumor, antibacterial and microbiota-regulating properties, and it has been explored as a treatment for breast cancer and as a means of preventing metastasis. What remained unexplored, the authors note, was exactly how baicalin’s influence on the gut microbiota might translate into protection against metastatic spread. The new experiments provide an answer that operates on two levels simultaneously. First, baicalin treatment reduced the abundance of A. putredinis in the gut, thinning the ranks of the metabolite-producing culprit. Second, and perhaps more intriguingly, baicalin modulated the tryptophan metabolism of the remaining A. putredinis, suppressing the bacterium’s production of IAA rather than simply killing the organism outright. The result was a double hit: fewer producers and less product.

The downstream consequences for the immune system were equally notable. Baicalin treatment inhibited lung metastasis and increased both the number and the cytotoxicity of CD8-positive T cells in the lungs. These cytotoxic T lymphocytes are the immune system’s primary assassins of tumor cells, and their presence and killing capacity in the lung, the organ where metastatic colonies were forming, suggests that baicalin effectively re-armed local immunity against disseminated cancer cells. The study thus sketches a coherent causal arc: chronic stress reshapes the gut microbiota, the reshaped community floods the host with IAA, IAA acts through AhR to make cancer cells more migratory and to degrade the immune environment at metastatic sites, and baicalin interrupts this cascade at the microbial source while simultaneously restoring the anti-tumor immune response.

To cement the causal role of the microbiota, the researchers deployed fecal microbiota transplantation, a technique that transfers the entire gut microbial community from one set of animals to another. By transplanting microbiota from baicalin-treated animals into untreated recipients, the team could confirm that the protective effects of the drug were genuinely mediated through the gut microbial community rather than through some independent action on the tumor cells themselves. This experimental logic is critical in microbiome research, where correlations between microbial abundance and disease outcomes abound but rigorous demonstrations of causation remain comparatively rare.

Perhaps the most clinically resonant finding comes from the human data. The researchers enrolled 60 breast cancer patients with metastasis at Yulin Red Cross Hospital in Guangxi, China, under an approved ethical protocol with informed written consent. In these patients, those with metastasis and severe depression, a proxy for the chronic stress state modeled in the mice, showed an increased abundance of A. putredinis in their feces and increased concentrations of IAA in their serum. The human correlative data thus mirror the mouse mechanistic data, suggesting that the stress-microbe-metabolite axis identified in the laboratory may also operate in patients. The authors are careful to frame these findings as revealing stress-driven microbiota and metabolite alterations that may facilitate breast cancer metastasis, a phrasing that acknowledges the correlative nature of the human component while emphasizing the mechanistic completeness of the animal work.

The implications of the study extend in several directions at once. For microbiome science, it adds a vivid example of how a psychological state can be transduced, via gut bacteria, into a circulating chemical signal with direct consequences for cancer behavior. The gut-brain axis has been implicated in mood, immunity and neurodegeneration, but a documented pathway from chronic stress through a named bacterial species and a named metabolite to a named signaling receptor in metastasizing cancer cells is an unusually complete chain. For oncology, it raises the possibility that microbial metabolites could serve as biomarkers of metastatic risk in stressed patients, or that microbiota-directed interventions could complement existing therapies. And for pharmacology, the work offers a mechanistic vindication of baicalin, a compound with deep roots in traditional Chinese medicine, by showing that its anti-metastatic effects may depend less on direct toxicity to tumor cells than on a sophisticated ecological intervention in the gut.

Considerable work remains before any of this reaches the clinic. The mouse findings were generated in the 4T1 model, and metastasis biology can differ substantially between mice and humans. The patient cohort, while valuable, demonstrates association rather than causation, and it remains to be seen whether lowering IAA through microbiota manipulation would genuinely reduce metastatic risk in people. Dosing, safety and the long-term ecological consequences of suppressing a common gut commensal all require scrutiny. Still, the study stands as a compelling demonstration that the road from a stressed mind to a spreading cancer may pass through the gut, and that an old herbal molecule, by quieting a single bacterial pathway, can help close it. The research was supported by the National Natural Science Foundation of China and several provincial and institutional funds, and the article is published open access in Microbiome.

Subject of Research: The role of the gut bacterium Alistipes putredinis and its metabolite indole-3-acetic acid in stress-driven breast cancer metastasis and its inhibition by baicalin

Article Title: Pharmacological inhibition of Alistipes putredinis-derived indole-3-acetic acid by baicalin suppresses stress-driven breast cancer metastasis

Article References: Tao, R., Wu, J., Mao, T., Zong, G., Pan, Y., Deng, R., Chen, W., Li, X., Shan, Y., Lu, Y., & Wei, Z. (2026). Pharmacological inhibition of Alistipes putredinis-derived indole-3-acetic acid by baicalin suppresses stress-driven breast cancer metastasis. Microbiome. https://doi.org/10.1186/s40168-026-02519-1

Image Credits: AI Generated

DOI: 10.1186/s40168-026-02519-1

Keywords: breast cancer, metastasis, chronic stress, gut microbiome, Alistipes putredinis, indole-3-acetic acid, baicalin, aryl hydrocarbon receptor, tryptophan metabolism, CD8 T cells, fecal microbiota transplantation, microbiota-gut-brain axis